Published in Cancer on February 15, 1998
Chronic disease in men with newly diagnosed cancer: a nested case-control study. Am J Epidemiol (2010) 1.58
Efficacy and safety of everolimus in elderly patients with metastatic renal cell carcinoma: an exploratory analysis of the outcomes of elderly patients in the RECORD-1 Trial. Eur Urol (2012) 1.50
Age, severe comorbidity and functional impairment independently contribute to poor survival in cancer patients. J Cancer Res Clin Oncol (2007) 1.33
The relationship of cancer symptom clusters to depressive affect in the initial phase of palliative radiation. J Pain Symptom Manage (2005) 1.19
Impairment in functional status and survival in patients with acute myeloid leukaemia. J Cancer Res Clin Oncol (2006) 1.16
Impact of age-related comorbidity on results of colorectal cancer surgery. World J Gastroenterol (2009) 0.98
Age is a prognostic factor affecting survival in lung cancer patients. Oncol Lett (2013) 0.88
Attribution of functional limitation to cancer decreases in the year following breast cancer diagnosis in older patients. Crit Rev Oncol Hematol (2008) 0.83
Cumulative financial stress and strain in palliative radiation outpatients: The role of age and disability. Acta Oncol (2005) 0.81
Temporal trends and predictors of perioperative chemotherapy use in elderly patients with resected nonsmall cell lung cancer. Cancer (2008) 0.80
Medical Decision-Making Incapacity among Newly Diagnosed Older Patients with Hematological Malignancy Receiving First Line Chemotherapy: A Cross-Sectional Study of Patients and Physicians. PLoS One (2015) 0.76
Frailty Markers and Treatment Decisions in Patients Seen in Oncogeriatric Clinics: Results from the ASRO Pilot Study. PLoS One (2016) 0.75
Primary Care Physicians' Perspectives of Their Role in Cancer Care: A Systematic Review. J Gen Intern Med (2016) 0.75
Performance status and comorbidity in elderly cancer patients compared with young patients with neoplasia and elderly patients without neoplastic conditions. Cancer (1999) 0.75
Oral capecitabine compared with intravenous fluorouracil plus leucovorin in patients with metastatic colorectal cancer: results of a large phase III study. J Clin Oncol (2001) 5.25
Treatment of advanced squamous-cell carcinoma of the head and neck with alternating chemotherapy and radiotherapy. N Engl J Med (1992) 3.21
First-line oral capecitabine therapy in metastatic colorectal cancer: a favorable safety profile compared with intravenous 5-fluorouracil/leucovorin. Ann Oncol (2002) 2.87
Primary mediastinal B-cell lymphoma with sclerosis: an aggressive tumor with distinctive clinical and pathologic features. J Clin Oncol (1993) 2.77
Randomized phase III trial evaluating the role of erythropoietin in the prevention of chemotherapy-induced anemia. J Clin Oncol (1997) 2.41
Five-year update of a randomized trial of alternating radiotherapy and chemotherapy compared with radiotherapy alone in treatment of unresectable squamous cell carcinoma of the head and neck. J Natl Cancer Inst (1996) 2.41
No standard treatment is available for advanced pancreatic cancer. Eur J Cancer (1995) 2.23
Epoetin alpha prevents anaemia and reduces transfusion requirements in patients undergoing primarily platinum-based chemotherapy for small cell lung cancer. Br J Cancer (1999) 2.22
Grant agencies must be seen to be fair. Nature (1999) 2.03
Prospective randomized trial of docetaxel versus mitomycin plus vinblastine in patients with metastatic breast cancer progressing despite previous anthracycline-containing chemotherapy. 304 Study Group. J Clin Oncol (1999) 1.98
Pattern of cancer risk in persons with AIDS in Italy in the HAART era. Br J Cancer (2009) 1.95
Central venous catheter-related complications in children with oncological/hematological diseases: an observational study of 418 devices. Ann Oncol (2005) 1.77
Diagnostic value of CYFRA 21-1 tumor marker and CEA in pleural effusion due to mesothelioma. Chest (2001) 1.71
Variations in the survival of adult cancer patients in Italy. Tumori (1997) 1.60
Synaptically mediated potentials elicited by the stimulation of post-ganglionic trunks in the guinea-pig superior cervical ganglion. Pflugers Arch (1970) 1.54
Weekly paclitaxel as first-line chemotherapy in elderly advanced breast cancer patients: a phase II study of the Gruppo Italiano di Oncologia Geriatrica (GIOGer). Ann Oncol (2005) 1.54
Adjuvant chemotherapy in the treatment of colon cancer: randomized multicenter trial of the Italian National Intergroup of Adjuvant Chemotherapy in Colon Cancer (INTACC). Ann Oncol (2003) 1.52
Participation of the dorsal periaqueductal grey matter in the hypoxic ventilatory response in unanaesthetized rats. Acta Physiol (Oxf) (2014) 1.45
Geriatric oncology: a clinical approach to the older patient with cancer. Eur J Cancer (2003) 1.45
Serum osteocalcin and bone mineral density at various skeletal sites: a study performed with three different assays. J Lab Clin Med (1997) 1.43
Short-term effect of exercise on platelet factor 4 in normal subjects and in patients with coronary artery disease. Cardiologia (1999) 1.42
Neurilemmoma of the ciliary body: report of a case. Br J Ophthalmol (1983) 1.41
West Nile encephalitis in Israel, 1999: the New York connection. Emerg Infect Dis (2001) 1.39
Sinus histiocytosis with massive lymphoadenopathy (Rosai-Dorfman disease). Clinico-pathological analysis of a paediatric case. Eur J Pediatr (1992) 1.38
Capecitabine in combination with preoperative radiation therapy in locally advanced, resectable, rectal cancer: a multicentric phase II study. Ann Oncol (2005) 1.37
Activity of gemcitabine in patients with non-small cell lung cancer: a multicentre, extended phase II study. Eur J Cancer (1996) 1.32
p53 status does not affect sensitivity of human ovarian cancer cell lines to paclitaxel. Cancer Res (1997) 1.31
Topical dimethylsulfoxide for the prevention of soft tissue injury after extravasation of vesicant cytotoxic drugs: a prospective clinical study. J Clin Oncol (1995) 1.30
Risk of cancer in persons with AIDS in Italy, 1985-1998. Br J Cancer (2003) 1.26
DNA damage induced by auramine O in liver, kidney, and bone marrow of rats and mice, and in a human cell line (alkaline elution assay and SCE induction). J Toxicol Environ Health (1982) 1.24
Evidence for a polyclonal nature of the cell infiltrate in sinus histiocytosis with massive lymphadenopathy (Rosai-Dorfman disease). Br J Haematol (1995) 1.19
Plasma and urinary levels of adriamycin in man. Eur J Cancer (1972) 1.19
Geographical variations of place of death among Italian communities suggest an inappropriate hospital use in the terminal phase of cancer disease. Public Health (2000) 1.19
Splenomegalic immunocytoma with circulating hairy cells. Report of eight cases and revision of the literature. Haematologica (1986) 1.19
Mortality among shipyard workers in Genoa, Italy. Ann N Y Acad Sci (1979) 1.18
Hyaluronidase as an antidote to extravasation of Vinca alkaloids: clinical results. J Cancer Res Clin Oncol (1994) 1.13
Geography of clinical cancer research publications from 1995 to 1999. Eur J Cancer (2003) 1.10
Pulmonary vein antral isolation for paroxysmal atrial fibrillation: results from long-term follow-up. J Cardiovasc Electrophysiol (2010) 1.09
Prevalence, distress, management, and relief of pain during the last 3 months of cancer patients' life. Results of an Italian mortality follow-back survey. Ann Oncol (2009) 1.09
Clinical results using the trochanter stabilizing plate (TSP): the modular extension of the dynamic hip screw (DHS) for internal fixation of selected unstable intertrochanteric fractures. J Orthop Trauma (1998) 1.09
Influence of age, the autonomic nervous system and anxiety on QT-interval variability. Clin Sci (Lond) (2001) 1.08
Assessing research productivity in an oncology research institute: the role of the documentation center. Bull Med Libr Assoc (1997) 1.08
Risk of cancer other than Kaposi's sarcoma and non-Hodgkin's lymphoma in persons with AIDS in Italy. Cancer and AIDS Registry Linkage Study. Br J Cancer (1998) 1.08
Adjuvant tamoxifen in primary breast cancer: influence on plasma lipids and antithrombin III levels. Breast Cancer Res Treat (1988) 1.07
Advanced colorectal cancer in the elderly: results of consecutive trials with 5-fluorouracil-based chemotherapy. Cancer Chemother Pharmacol (1998) 1.06
Early behavioral development in autistic children: the first 2 years of life through home movies. Psychopathology (2001) 1.05
C-C chemokines, IL-16, and soluble antiviral factor activity are increased in cloned T cells from subjects with long-term nonprogressive HIV infection. J Immunol (1997) 1.05
Amenorrhea induced by adjuvant chemotherapy in early breast cancer patients: prognostic role and clinical implications. Breast Cancer Res Treat (1997) 1.05
Paederus fuscipes dermatitis. A histopathological study. Am J Dermatopathol (1991) 1.04
Doxorubicin versus doxorubicin and cisplatin in endometrial carcinoma: definitive results of a randomised study (55872) by the EORTC Gynaecological Cancer Group. Ann Oncol (2003) 1.04
Impact of administration-related factors on outcome of adjuvant chemotherapy for primary breast cancer. Am J Clin Oncol (1989) 1.04
A randomized trial comparing cisplatin plus cyclophosphamide versus cisplatin, doxorubicin, and cyclophosphamide in advanced ovarian cancer. J Clin Oncol (1986) 1.04
Cancer stem cells and epithelial-mesenchymal transition: revisiting minimal residual disease. Curr Cancer Drug Targets (2010) 1.03
Five years' follow-up of severely injured ICU patients. J Trauma (1991) 1.03
Discharge properties and innervation of the sensory units in the crista ampullaris. Arch Sci Biol (Bologna) (1976) 1.02
Incidence of thyroid cancer in Italy, 1991-2005: time trends and age-period-cohort effects. Ann Oncol (2010) 1.02
Studies on DNA binding of caffeine and derivatives: evidence of intercalation by DNA-unwinding experiments. Biochim Biophys Acta (1989) 1.01
Synergism and lack of cross-resistance between short-term and continuous exposure to fluorouracil in human colon adenocarcinoma cells. J Natl Cancer Inst (1993) 1.01
Classic Kaposi's sarcoma in Italy, 1985-1998. Br J Cancer (2005) 1.01
Operative treatment of distal humeral fractures in the elderly. J Bone Joint Surg Br (1994) 1.01
Relative survival in elderly European cancer patients: evidence for health care inequalities. The EUROCARE Working Group. Crit Rev Oncol Hematol (2000) 1.00
DDP-induced cytotoxicity is not influenced by p53 in nine human ovarian cancer cell lines with different p53 status. Br J Cancer (1997) 0.99
DNA-damaging activity in vivo and bacterial mutagenicity of sixteen hydrazine derivatives as related quantitatively to their carcinogenicity. Cancer Res (1981) 0.98
Effect of Triton WR 1339 on cancer dissemination and metastases. Eur J Cancer (1969) 0.98
The incidence of narcotic-induced emesis. J Pain Symptom Manage (1991) 0.97
Increased invasive, chemotactic and locomotive abilities of c-Ha-ras-transformed human breast epithelial cells. Invasion Metastasis (1991) 0.97
Immunophenotypic characterization of the cell infiltrate in five cases of sinus histiocytosis with massive lymphadenopathy (Rosai-Dorfman disease). Hum Pathol (1992) 0.97
32P-postlabeling detection of DNA adducts in mice treated with the herbicide Roundup. Environ Mol Mutagen (1998) 0.96
Quantitative studies on cancer dissemination. Cancer Res (1969) 0.96
Relative survival in elderly cancer patients in Europe. EUROCARE Working Group. Eur J Cancer (1998) 0.96
Treatment of children over the age of one year with unresectable localised neuroblastoma without MYCN amplification: results of the SIOPEN study. Eur J Cancer (2013) 0.95
Accelerated versus standard cyclophosphamide, epirubicin and 5-fluorouracil or cyclophosphamide, methotrexate and 5-fluorouracil: a randomized phase III trial in locally advanced breast cancer. Ann Oncol (2003) 0.95
HER2 expression and efficacy of dose-dense anthracycline-containing adjuvant chemotherapy in breast cancer patients. Br J Cancer (2005) 0.95
Chemotaxis of 3T3 and SV3T3 cells to fibronectin is mediated through the cell-attachment site in fibronectin and a fibronectin cell surface receptor. J Cell Biol (1987) 0.95
Semen analysis in HIV seropositive men and in subjects at high risk for HIV infection. Hum Reprod (1996) 0.95
Power spectral analysis of heart rate variability in obese subjects: evidence of decreased cardiac sympathetic responsiveness. Int J Obes Relat Metab Disord (1996) 0.95
Combined chemotherapy and radiation therapy in advanced inoperable squamous cell carcinoma of the head and neck. The final report of a randomized trial. Cancer (1991) 0.95
Twenty-four hour heart period variability in systemic sclerosis. J Rheumatol (1996) 0.95
T cell receptor repertoire and function in patients with DiGeorge syndrome and velocardiofacial syndrome. Clin Exp Immunol (2000) 0.94
Glomerular clusterin is associated with PKC-alpha/beta regulation and good outcome of membranous glomerulonephritis in humans. Kidney Int (2006) 0.94
Activation of the efferent system in the isolated frog labyrinth: effects on the afferent EPSPs and spike discharge recorded from single fibres of the posterior nerve. Brain Res (1980) 0.94
Impairement of drug metabolism in tumor-bearing animals. Eur J Cancer (1971) 0.94
Linkage of AIDS and cancer registries in Italy. Int J Cancer (1998) 0.93
Locally advanced non-metastatic breast cancer: analysis of prognostic factors in 125 patients homogeneously treated with a combined modality approach. Eur J Cancer (1995) 0.93
Inhibition of cancer cell growth and c-Myc transcriptional activity by a c-Myc helix 1-type peptide fused to an internalization sequence. Cancer Res (1998) 0.93
Heart rate and blood pressure variability in obese normotensive subjects. Int J Obes Relat Metab Disord (1998) 0.93
Cerebral metastases secondary to ovarian cancer: still an unusual event. Gynecol Oncol (1993) 0.93
Is there a relationship between high C-reactive protein (CRP) levels and dementia? Arch Gerontol Geriatr (2009) 0.93
Staphylinid blister beetle dermatitis. Contact Dermatitis (2002) 0.92
Age-adjusted normal confidence intervals for heart rate variability in healthy subjects during head-up tilt. Int J Cardiol (1995) 0.92
Expression of HLA-DR in granulocytes of polytraumatized patients treated with recombinant human granulocyte macrophage-colony-stimulating factor. Hum Immunol (1995) 0.92
Clinicopathologic and immunologic characteristics of non-Hodgkin's lymphomas presenting in the orbit. A report of eight cases. Cancer (1985) 0.92
Cooperation between p53 and hMLH1 in a human colocarcinoma cell line in response to DNA damage. Clin Cancer Res (1999) 0.92